CTAS

Cintas Corp

Add to Watchlist

Advanced Chart

212.990

+1.13(0.533%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

213.550

Open

211.800

VWAP

213.03

Vol

3.07M

Mkt Cap

85.83B

Low

211.350

Amount

654.65M

EV/EBITDA(TTM)

29.57

Total Shares

101.46M

87.54B

EV/OCF(TTM)

40.42

P/S(TTM)

8.41

Cintas Corporation develops uniform programs using fabric. The Company helps businesses of all types and sizes, primarily in the United States, as well as Canada and Latin America. The Company operates through two segments: Uniform Rental and Facility Services segment and the First Aid and Safety Services segment. The Uniform Rental and Facility Services segment consists of the rental and servicing of uniforms and other garments, including flame resistant clothing, mats, mops and shop towels and other ancillary items. This segment also includes restroom cleaning services and supplies and the sale of items from its catalogs to its customers. The First Aid and Safety Services segment consists of first aid and safety products and services. The remainder of its segments, which consists of the Fire Protection Services segment and the Uniform Direct Sale segment, is included in All Other. It provides its products and services to small service and manufacturing companies and to corporations.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2026Q2

FY2026Q3

2.70B

+7.94%

1.196

+8.72%

2.76B

+7.84%

1.212

+11.23%

2.81B

+7.58%

1.234

+9.22%

Estimates Revision

The market is revising Upward the revenue expectations for Cintas Corporation (CTAS) for FY2026, with the revenue forecasts being adjusted by 0.66% over the past three months. During the same period, the stock price has changed by -5.71%.

Revenue Estimates for FY2026

Revise Upward

+0.66%

In Past 3 Month

EPS Estimates for FY2026

Revise Upward

+0.05%

In Past 3 Month

Stock Price

Go Down

-5.71%

In Past 3 Month

14 Analyst Rating

9.71% Upside

Wall Street analysts forecast CTAS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTAS is 233.67 USD with a low forecast of 172.00 USD and a high forecast of 257.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

6 Hold

1 Sell

Moderate Buy

9.71% Upside

Current: 212.990

Low

172.00

Averages

233.67

High

257.00

9.71% Upside

Current: 212.990

Low

172.00

Averages

233.67

High

257.00

Truist

Buy

maintain

$240 -> $265

2025-08-14

Reason

Truist

Price Target

$240 -> $265

2025-08-14

maintain

Buy

Reason

Truist raised the firm's price target on Cintas to $265 from $240 and keeps a Buy rating on the shares. The firm has increased conviction in the company's growth algorithm after meeting with management. Cintas has a "long runway" for double-digit organic growth in its First Aid segment and can expand margins, the analyst tells investors in a research note.

Truist

Buy

maintain

$240 -> $255

2025-08-14

Reason

Truist

Price Target

$240 -> $255

2025-08-14

maintain

Buy

Reason

Truist raised the firm's price target on Cintas to $255 from $240 and keeps a Buy rating on the shares. The firm has increased conviction in the company's growth algorithm after meeting with management. Cintas has a "long runway" for double-digit organic growth in its First Aid segment and can expand margins, the analyst tells investors in a research note.

Morgan Stanley

analyst

Equal Weight

maintain

$213 -> $220

2025-07-18

Reason

Morgan Stanley

analyst

Price Target

$213 -> $220

2025-07-18

maintain

Equal Weight

Reason

Morgan Stanley raised the firm's price target on Cintas to $220 from $213 and keeps an Equal Weight rating on the shares. Organic revenue growth in the quarter and revenue guidance of 7.1% at the mid-point were ahead of the firm and consensus forecast, though EPS guidance of $4.78 at the mid-point was below the firm's view and consensus, notes the analyst, who views continued strength as priced in.

Baird

Neutral

maintain

$227 -> $230

2025-07-18

Reason

Baird

Price Target

$227 -> $230

2025-07-18

maintain

Neutral

Reason

Baird raised the firm's price target on Cintas to $230 from $227 and keeps a Neutral rating on the shares.

UBS

Buy

maintain

$240 -> $255

2025-07-18

Reason

UBS

Price Target

$240 -> $255

2025-07-18

maintain

Buy

Reason

UBS raised the firm's price target on Cintas to $255 from $240 and keeps a Buy rating on the shares.

JPMorgan

NULL -> Overweight

initiated

$239

2025-07-14

Reason

JPMorgan

Price Target

$239

2025-07-14

initiated

NULL -> Overweight

Reason

JPMorgan resumed coverage of Cintas with an Overweight rating and $239 price target following a period of restriction. The firm views Cintas as a core holding in the uniform services group with compounding growth. The company has shown consistent execution across a range of macroeconomic backdrops over the last two decades, the analyst tells investors in a research note.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Cintas Corp (CTAS.O) is 43.86, compared to its 5-year average forward P/E of 37.39. For a more detailed relative valuation and DCF analysis to assess Cintas Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued

5Y Average PE

37.39

Current PE

43.86

Overvalued PE

42.79

Undervalued PE

32.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Overvalued

5Y Average EV/EBITDA

23.89

Current EV/EBITDA

28.50

Overvalued EV/EBITDA

27.50

Undervalued EV/EBITDA

20.28

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued

5Y Average PS

5.83

Current PS

7.69

Overvalued PS

7.04

Undervalued PS

4.62